Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
出版年份 2021 全文链接
标题
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 6, Pages 2939
出版商
MDPI AG
发表日期
2021-03-15
DOI
10.3390/ijms22062939
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic antisense oligonucleotides for movement disorders
- (2020) Epaminondas Doxakis MEDICINAL RESEARCH REVIEWS
- Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
- (2020) Diana Alarcón-Arís et al. EBioMedicine
- Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration
- (2019) Alevtina Zharikov et al. NEUROBIOLOGY OF DISEASE
- Nucleic Acid–Based Therapeutics for Parkinson’s Disease
- (2019) Masayuki Nakamori et al. Neurotherapeutics
- Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
- (2019) Brian Spencer et al. NEUROBIOLOGY OF DISEASE
- Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
- (2019) Heather Wilson et al. LANCET NEUROLOGY
- Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease
- (2019) Tommi Kilpeläinen et al. Scientific Reports
- Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease
- (2018) Diana Alarcón-Arís et al. MOLECULAR THERAPY
- Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
- (2018) S. Pablo Sardi et al. MOVEMENT DISORDERS
- Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
- (2018) Matthew J. Benskey et al. Frontiers in Molecular Neuroscience
- Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression
- (2018) M. Neus Fullana et al. MOLECULAR NEUROBIOLOGY
- Therapeutic Oligonucleotides: State of the Art
- (2018) C.I. Edvard Smith et al. Annual Review of Pharmacology and Toxicology
- Viral Vector-Mediated Antisense Therapy for Genetic Diseases
- (2017) Marine Imbert et al. Genes
- Advances in Non-Viral DNA Vectors for Gene Therapy
- (2017) Cinnamon Hardee et al. Genes
- Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s Disease
- (2017) Christin Helmschrodt et al. Molecular Therapy-Nucleic Acids
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
- (2016) Timothy J. Collier et al. Frontiers in Neuroscience
- Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
- (2015) A Ferrés-Coy et al. MOLECULAR PSYCHIATRY
- DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
- (2015) Kazutaka Nishina et al. Nature Communications
- Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
- (2014) Amy Reeve et al. AGEING RESEARCH REVIEWS
- Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
- (2013) Adam W. Oaks et al. PLoS One
- -Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis
- (2012) D. Scott et al. JOURNAL OF NEUROSCIENCE
- Click-Modified Anandamide siRNA Enables Delivery and Gene Silencing in Neuronal and Immune Cells
- (2012) Julian Willibald et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Synuclein modulation of monoamine transporters
- (2011) Adam W. Oaks et al. FEBS LETTERS
- E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
- (2011) Kristel L. Emmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects
- (2011) A Bortolozzi et al. MOLECULAR PSYCHIATRY
- Targeted Intracellular Delivery of Antisense Oligonucleotides via Conjugation with Small-Molecule Ligands
- (2010) Osamu Nakagawa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration
- (2010) Oleg S Gorbatyuk et al. MOLECULAR THERAPY
- A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
- (2010) Alexander Kurz et al. PLoS One
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- Propagation of host disease to grafted neurons: Accumulating evidence
- (2009) Jeffrey H. Kordower et al. EXPERIMENTAL NEUROLOGY
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein
- (2009) P. Desplats et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Motor impairment and aberrant production of neurochemicals in human α-synuclein A30P+A53T transgenic mice with α-synuclein pathology
- (2008) Masaki Ikeda et al. BRAIN RESEARCH
- In vivo silencing of alpha-synuclein using naked siRNA
- (2008) Jada Lewis et al. Molecular Neurodegeneration
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: Methodology and biological significance
- (2008) Kelly Lengyel et al. NEUROPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search